Logo image of BHR

BRAEMAR HOTELS & RESORTS INC (BHR) Stock Fundamental Analysis

NYSE:BHR - New York Stock Exchange, Inc. - US10482B1017 - REIT - Currency: USD

2.58  -0.03 (-1.15%)

After market: 2.58 0 (0%)

Fundamental Rating

2

Overall BHR gets a fundamental rating of 2 out of 10. We evaluated BHR against 129 industry peers in the Diversified REITs industry. BHR has a bad profitability rating. Also its financial health evaluation is rather negative. BHR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

BHR had negative earnings in the past year.
In the past year BHR had a positive cash flow from operations.
BHR had negative earnings in each of the past 5 years.
BHR had a positive operating cash flow in 4 of the past 5 years.
BHR Yearly Net Income VS EBIT VS OCF VS FCFBHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M -200M

1.2 Ratios

BHR has a worse Return On Assets (-2.34%) than 78.57% of its industry peers.
BHR's Return On Equity of -6.91% is on the low side compared to the rest of the industry. BHR is outperformed by 75.40% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.77%, BHR is doing worse than 75.40% of the companies in the same industry.
BHR had an Average Return On Invested Capital over the past 3 years of 1.72%. This is in line with the industry average of 3.11%.
The last Return On Invested Capital (1.77%) for BHR is above the 3 year average (1.72%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -2.34%
ROE -6.91%
ROIC 1.77%
ROA(3y)-1.97%
ROA(5y)-2.68%
ROE(3y)-6.19%
ROE(5y)-10.17%
ROIC(3y)1.72%
ROIC(5y)N/A
BHR Yearly ROA, ROE, ROICBHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10 -20 -30

1.3 Margins

BHR has a worse Operating Margin (5.81%) than 86.51% of its industry peers.
In the last couple of years the Operating Margin of BHR has declined.
The Gross Margin of BHR (69.13%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of BHR has remained more or less at the same level.
Industry RankSector Rank
OM 5.81%
PM (TTM) N/A
GM 69.13%
OM growth 3YN/A
OM growth 5Y-6.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.06%
GM growth 5Y-0.43%
BHR Yearly Profit, Operating, Gross MarginsBHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60

More info and screens

2

2. Health

2.1 Basic Checks

BHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
BHR has less shares outstanding than it did 1 year ago.
BHR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BHR has an improved debt to assets ratio.
BHR Yearly Shares OutstandingBHR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
BHR Yearly Total Debt VS Total AssetsBHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

Based on the Altman-Z score of 0.21, we must say that BHR is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BHR (0.21) is worse than 72.22% of its industry peers.
BHR has a Debt/Equity ratio of 1.64. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.64, BHR is doing worse than 67.46% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.64
Debt/FCF N/A
Altman-Z 0.21
ROIC/WACC0.24
WACC7.29%
BHR Yearly LT Debt VS Equity VS FCFBHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B

2.3 Liquidity

BHR has a Current Ratio of 1.17. This is a normal value and indicates that BHR is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.17, BHR perfoms like the industry average, outperforming 51.59% of the companies in the same industry.
BHR has a Quick Ratio of 1.15. This is a normal value and indicates that BHR is financially healthy and should not expect problems in meeting its short term obligations.
BHR has a Quick ratio (1.15) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.15
BHR Yearly Current Assets VS Current LiabilitesBHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

2

3. Growth

3.1 Past

BHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.50%, which is quite good.
The Revenue has decreased by -0.11% in the past year.
BHR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.38% yearly.
EPS 1Y (TTM)12.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96%
Revenue 1Y (TTM)-0.11%
Revenue growth 3Y48.23%
Revenue growth 5Y11.38%
Sales Q2Q%-7.14%

3.2 Future

BHR is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -16.17% yearly.
BHR is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.65% yearly.
EPS Next Y38.18%
EPS Next 2Y-16.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-2.31%
Revenue Next 2Y-2.65%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BHR Yearly Revenue VS EstimatesBHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
BHR Yearly EPS VS EstimatesBHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1 -2 -3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BHR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BHR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BHR Price Earnings VS Forward Price EarningsBHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BHR indicates a rather cheap valuation: BHR is cheaper than 92.86% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.45
BHR Per share dataBHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

A cheap valuation may be justified as BHR's earnings are expected to decrease with -16.17% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.17%
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

BHR has a Yearly Dividend Yield of 7.66%, which is a nice return.
The stock price of BHR dropped by -25.86% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
BHR's Dividend Yield is rather good when compared to the industry average which is at 18.40. BHR pays more dividend than 81.75% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.27, BHR pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.66%

5.2 History

The dividend of BHR decreases each year by -3.87%.
BHR has paid a dividend for at least 10 years, which is a reliable track record.
BHR has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-3.87%
Div Incr Years1
Div Non Decr Years2
BHR Yearly Dividends per shareBHR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

BHR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The Dividend Rate of BHR has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP-102.5%
EPS Next 2Y-16.17%
EPS Next 3YN/A
BHR Yearly Income VS Free CF VS DividendBHR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100M -200M

More info and screens

BRAEMAR HOTELS & RESORTS INC

NYSE:BHR (2/21/2025, 8:04:00 PM)

After market: 2.58 0 (0%)

2.58

-0.03 (-1.15%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-11 2024-11-11/dmh
Earnings (Next)02-26 2025-02-26/amc
Inst Owners50.9%
Inst Owner Change-0.8%
Ins Owners1.3%
Ins Owner Change0.35%
Market Cap171.62M
Analysts46.67
Price Target3.06 (18.6%)
Short Float %1.35%
Short Ratio3.1
Dividend
Industry RankSector Rank
Dividend Yield 7.66%
Yearly Dividend0.77
Dividend Growth(5Y)-3.87%
DP-102.5%
Div Incr Years1
Div Non Decr Years2
Ex-Date03-31 2025-03-31 (0.05)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)23.68%
Min EPS beat(2)-48.51%
Max EPS beat(2)95.87%
EPS beat(4)2
Avg EPS beat(4)38.87%
Min EPS beat(4)-50.11%
Max EPS beat(4)158.24%
EPS beat(8)3
Avg EPS beat(8)16.64%
EPS beat(12)6
Avg EPS beat(12)38.94%
EPS beat(16)9
Avg EPS beat(16)30.37%
Revenue beat(2)1
Avg Revenue beat(2)-2.33%
Min Revenue beat(2)-4.99%
Max Revenue beat(2)0.34%
Revenue beat(4)3
Avg Revenue beat(4)-0.38%
Min Revenue beat(4)-4.99%
Max Revenue beat(4)2.96%
Revenue beat(8)6
Avg Revenue beat(8)0.2%
Revenue beat(12)9
Avg Revenue beat(12)2.16%
Revenue beat(16)13
Avg Revenue beat(16)3.22%
PT rev (1m)-7.69%
PT rev (3m)-14.29%
EPS NQ rev (1m)-24.24%
EPS NQ rev (3m)-24.24%
EPS NY rev (1m)0%
EPS NY rev (3m)34.86%
Revenue NQ rev (1m)-3.95%
Revenue NQ rev (3m)-3.95%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.23
P/FCF N/A
P/OCF 2.39
P/B 0.23
P/tB 0.23
EV/EBITDA 8.45
EPS(TTM)-0.77
EYN/A
EPS(NY)-1.57
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)1.08
OCFY41.88%
SpS11.01
BVpS11.09
TBVpS11.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.34%
ROE -6.91%
ROCE 2.13%
ROIC 1.77%
ROICexc 1.93%
ROICexgc 1.96%
OM 5.81%
PM (TTM) N/A
GM 69.13%
FCFM N/A
ROA(3y)-1.97%
ROA(5y)-2.68%
ROE(3y)-6.19%
ROE(5y)-10.17%
ROIC(3y)1.72%
ROIC(5y)N/A
ROICexc(3y)1.88%
ROICexc(5y)N/A
ROICexgc(3y)1.9%
ROICexgc(5y)N/A
ROCE(3y)2.08%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-3.21%
ROICexc growth 3YN/A
ROICexc growth 5Y-2.85%
OM growth 3YN/A
OM growth 5Y-6.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.06%
GM growth 5Y-0.43%
F-Score7
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 1.64
Debt/FCF N/A
Debt/EBITDA 8.43
Cap/Depr 75.84%
Cap/Sales 10.42%
Interest Coverage 0.42
Cash Conversion 50.17%
Profit Quality N/A
Current Ratio 1.17
Quick Ratio 1.15
Altman-Z 0.21
F-Score7
WACC7.29%
ROIC/WACC0.24
Cap/Depr(3y)219.37%
Cap/Depr(5y)209.36%
Cap/Sales(3y)26.94%
Cap/Sales(5y)28.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96%
EPS Next Y38.18%
EPS Next 2Y-16.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.11%
Revenue growth 3Y48.23%
Revenue growth 5Y11.38%
Sales Q2Q%-7.14%
Revenue Next Year-2.31%
Revenue Next 2Y-2.65%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-37.17%
EBIT growth 3YN/A
EBIT growth 5Y3.83%
EBIT Next Year195.72%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y84.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.34%
OCF growth 3YN/A
OCF growth 5Y3.68%